The MHRA has not issued specific guidance on cagrilintide or retatrutide as neither is currently licensed in the UK
Drug Pathway: No FDA New Drug Approval The FDA drug approval system is based on the NDA (New Drug Application) process
Athletes, fitness enthusiasts, body builders, especially those in muscle-building or cutting phases Marathon runners, triathletes, CrossFit, and endurance training People recovering from intense physical activity, or those with jobs with high-heat or physical exertion ( e.g
Sites : Abdomen (most common) Front of thigh Back of upper arm Process : Clean site with alcohol Draw dose into insulin syringe Pinch skin Insert at 45-90 degree angle Inject slowly Dispose needle safely Timing : Morning preferred (supports daytime tissue repair) Rotating sites : Prevents tissue damage Protocol duration Acute inflammation : 6-8 weeks minimum Skin/anti-aging : 12-24 weeks for significant results Chronic conditions : 12+ weeks, may use long-term Maintenance : Some use 1mg 3-4x weekly after initial protocol Cycling : Not required
JL: Data curation, Methodology, Writing review and editing
Future Prospects in San Francisco The future of peptide-based treatments for psoriasis in San Francisco looks promising